Rectify Pharmaceuticals Competitors and Similar CompaniesClear all
Rectify Pharmaceuticals's competitors and similar companies include Wings Therapeutics.
 Rectify Pharmaceuticals Rectify Pharmaceuticals is a company developing disease-modifying precision therapies that restore ABC transporter function to address the underlying cause of serious genetic diseases. |  Wings Therapeutics Wings Therapeutics is a biotechnology company engaged in the development of therapies for patients suffering from Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin blistering disease. | |
Founding Date | Founding Date 2020 | Founding Date 2019 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations Berkeley, US HQ |
Employees | Employees 254% increase | Employees 5 |
Funding | ||
Latest funding round | Latest funding round $ 100m (over 4 years ago) | Latest funding round $ 1.5m (almost 7 years ago) |
Total funding raised | Total funding raised $ 100m | Total funding raised $ 1.5m |
For sources of this data, please see the company profile
View Company Profiles
Wings Therapeutics
HQ
Berkeley, US
Employees
5
Wings Therapeutics is a biotechnology company engaged in the development of therapies for patients suffering from Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin blistering disease.
View company